This contract expires in 84 days (Sep 30, 2026).

Browse related active opportunities

DEFINITIVE CONTRACT

INSTITUT DE FORMULATION DES VACCINS (CH) SA - ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES

PIID: 75N93023C00048
Effective Date: Sep 30, 2023End Date: Closes in 84 days
Award $
$6.9M
Vendor
INSTITUT DE FORMULATION DES VACCINS (CH) SA

Key Details

Dollars Obligated
$6.9M
Awarding Sub-Agency
National Institutes of Health

Description

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES

Context & Analysis

Department of Health and Human Services obligated $6,937,092.07 to INSTITUT DE FORMULATION DES VACCINS (CH) SA for advanced development of lq a liposome-based saponin-containing adjuvant for use in pansarbecovirus vaccines. The contract is scheduled through Sep 30, 2026 — approximately 3 months remaining. This award is one of several similar procurements from Department of Health and Human Services — related awards are listed below.

Contractor Information

UEI: N773KSZMJA78
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related